Inspire Medical Systems Inc

INSP

65.700USD

+0.120+0.18%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

Inspire Medical Systems Inc's Score

Industry at a Glance

Industry Ranking

67 / 205

Overall Ranking

178 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Inspire Medical Systems Inc Highlights

StrengthsRisks

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 96.84% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Fairly Valued

The company’s latest PE is 43.82, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 33.76M shares, decreasing 16.75% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 210.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.56.

Analyst Rating

Based on 19 analysts

Buy

Current Rating

128.400

Target Price

+88.19%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Inspire Medical Systems Inc is 9.07, ranking 18 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 224.50M, representing a year-over-year increase of 10.49%, while its net profit experienced a year-over-year increase of 46.30%.

Score

Industry at a Glance

Previous score

9.07

Change

0



Financials

9.81

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.78

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.31

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.47

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Inspire Medical Systems Inc is 4.60, ranking 191 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 43.82, which is 2257.32% below the recent high of 1033.03 and 1182.53% above the recent low of -474.39.

Score

Industry at a Glance

Previous score

4.60

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 67/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Inspire Medical Systems Inc is 7.47, ranking 131 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 127.50, with a high of 180.00 and a low of 81.00.

Score

Industry at a Glance

Previous score

7.47

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Inspire Medical Systems Inc is 6.39, ranking 150 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 90.64 and the support level at 52.77, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.36

Change

0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Inspire Medical Systems Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 116.17%, representing a quarter-over-quarter increase of 4.55%. The largest institutional shareholder is The Vanguard, holding a total of 2.95M shares, representing 10.14% of shares outstanding, with 7.09% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.19M

-8.69%

The Vanguard Group, Inc.

Star Investors

2.99M

-6.37%

Citadel Advisors LLC

1.71M

-2.02%

Deerfield Management Company, L.P.

1.48M

+40.91%

William Blair Investment Management, LLC

1.30M

+68.70%

State Street Investment Management (US)

979.31K

-5.00%

Braidwell LP

883.75K

+69.17%

Soleus Capital Management, L.P.

728.19K

+568.06%

Janus Henderson Investors

667.08K

+4.08%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Inspire Medical Systems Inc is 4.13, ranking 110 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Inspire Medical Systems Inc

INSP

7.14 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment